Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mode of progression in smoldering multiple myeloma: a study of 406 patients.
Abdallah NH, Lakshman A, Kumar SK, Cook J, Binder M, Kapoor P, Dispenzieri A, Gertz MA, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Lin Y, Kourelis T, Warsame R, Bergsagel L, Rajkumar SV. Abdallah NH, et al. Among authors: bergsagel l. Blood Cancer J. 2024 Jan 17;14(1):9. doi: 10.1038/s41408-024-00980-5. Blood Cancer J. 2024. PMID: 38228628 Free PMC article.
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.
Kumar S, Fonseca R, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Hayman SR, Buadi FK, Dingli D, Knudson RA, Greenberg A, Russell SJ, Zeldenrust SR, Lust JA, Kyle RA, Bergsagel L, Rajkumar SV. Kumar S, et al. Among authors: bergsagel l. Blood. 2012 Mar 1;119(9):2100-5. doi: 10.1182/blood-2011-11-390658. Epub 2012 Jan 10. Blood. 2012. PMID: 22234687 Free PMC article.
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.
Kumar SK, Hayman SR, Buadi FK, Roy V, Lacy MQ, Gertz MA, Allred J, Laumann KM, Bergsagel LP, Dingli D, Mikhael JR, Reeder CB, Stewart AK, Zeldenrust SR, Greipp PR, Lust JA, Fonseca R, Russell SJ, Rajkumar SV, Dispenzieri A. Kumar SK, et al. Blood. 2012 May 24;119(21):4860-7. doi: 10.1182/blood-2012-01-407791. Epub 2012 Apr 13. Blood. 2012. PMID: 22504925 Free PMC article. Clinical Trial.
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities.
Abdallah N, Greipp P, Kapoor P, Gertz MA, Dispenzieri A, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Bergsagel L, Ketterling R, Rajkumar SV, Kumar SK. Abdallah N, et al. Among authors: bergsagel l. Blood Adv. 2020 Aug 11;4(15):3509-3519. doi: 10.1182/bloodadvances.2020002218. Blood Adv. 2020. PMID: 32750129 Free PMC article.
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
Abdallah N, Rajkumar SV, Greipp P, Kapoor P, Gertz MA, Dispenzieri A, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Bergsagel L, Ketterling R, Kumar SK. Abdallah N, et al. Among authors: bergsagel l. Blood Cancer J. 2020 Aug 11;10(8):82. doi: 10.1038/s41408-020-00348-5. Blood Cancer J. 2020. PMID: 32782240 Free PMC article.
Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma.
Abdallah N, Baughn LB, Rajkumar SV, Kapoor P, Gertz MA, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Ketterling R, Bergsagel L, Greipp P, Kumar SK. Abdallah N, et al. Among authors: bergsagel l. Clin Cancer Res. 2020 Dec 15;26(24):6581-6588. doi: 10.1158/1078-0432.CCR-20-2283. Epub 2020 Oct 2. Clin Cancer Res. 2020. PMID: 33008815 Free PMC article.
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
Abeykoon JP, Vaxman J, Patel SV, Kumar S, Malave GC, Young KS, Ailawadhi S, Larsen JT, Dispenzieri A, Muchtar E, Gonsalves WI, Kourelis T, Leung N, Warsame R, Go RS, Bergsagel L, Lacy MQ, Rajkumar SV, Gertz MA, Kapoor P. Abeykoon JP, et al. Among authors: bergsagel l. Br J Haematol. 2022 Oct;199(1):95-99. doi: 10.1111/bjh.18298. Epub 2022 Jun 13. Br J Haematol. 2022. PMID: 35694818
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Ho M, Zanwar S, Buadi FK, Ailawadhi S, Larsen J, Bergsagel L, Binder M, Chanan-Khan A, Dingli D, Dispenzieri A, Fonseca R, Gertz MA, Gonsalves W, Go RS, Hayman S, Kapoor P, Kourelis T, Lacy MQ, Leung N, Lin Y, Muchtar E, Roy V, Sher T, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Rajkumar SV, Kumar S. Ho M, et al. Among authors: bergsagel l. Blood. 2022 Nov 3;140(18):1997-2000. doi: 10.1182/blood.2022017616. Blood. 2022. PMID: 36096078 Free PMC article.
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
Ho M, Zanwar S, Buadi FK, Ailawadhi S, Larsen J, Bergsagel L, Binder M, Chanan-Khan A, Dingli D, Dispenzieri A, Fonseca R, Gertz MA, Gonsalves W, Go RS, Hayman S, Kapoor P, Kourelis T, Lacy MQ, Leung N, Lin Y, Muchtar E, Roy V, Sher T, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Rajkumar SV, Kumar S. Ho M, et al. Among authors: bergsagel l. Am J Hematol. 2023 Jan;98(1):49-55. doi: 10.1002/ajh.26762. Epub 2022 Oct 24. Am J Hematol. 2023. PMID: 36226510 Free PMC article.
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
Zanwar S, Ho M, Buadi FK, Ailawadhi S, Larsen J, Bergsagel L, Binder M, Chanan-Khan A, Dingli D, Dispenzieri A, Fonseca R, Gertz MA, Gonsalves W, Go RS, Hayman S, Kapoor P, Kourelis T, Lacy MQ, Leung N, Lin Y, Muchtar E, Roy V, Sher T, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Vincent Rajkumar S, Kumar S. Zanwar S, et al. Among authors: bergsagel l. Blood Cancer J. 2022 Nov 24;12(11):160. doi: 10.1038/s41408-022-00752-z. Blood Cancer J. 2022. PMID: 36424376 Free PMC article. No abstract available.
36 results